ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 blockbusters.
Announcement as on 20 November 2025

Eli Lilly wants to be part of making a big dent in obesity and diabetes, says co's India head Winselow Tucker
Eli Lilly India chief Winselow Tucker said the company’s strategy of combining a strong product with ecosystem partnerships and patient education has helped drive early momentum for Mounjaro in India, where the dual-action diabetes and obesity drug has clo
Announcement as on 19 November 2025

Eli Lilly get nod from CDSCO for it Alzheimer’s drug Donanemab
Eli Lilly has secured marketing authorization from India's CDSCO for its Alzheimer's drug, donanemab. This new disease-modifying therapy targets amyloid plaques, offering a significant milestone in addressing the urgent needs of early-stage Alzheimer's pat
Announcement as on 18 November 2025

Patent expiry looms: Eli Lilly and Novo Nordisk strategise to defend their top obesity drugs in India
Eli Lilly and Novo Nordisk leaders share their India strategies for weight-loss drugs. They focus on pricing, market expansion and countering generics after semaglutide's patent ends. Both companies aim to increase patient access to their innovative thera
Announcement as on 18 November 2025

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?
Key PointsPfizer's CEO thinks his company will make big waves in the weight loss market.
Announcement as on 18 November 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 911.68
  • 12Day Average: 926.37
  • 20Day Average: 920.36
  • 50Day Average: 970.63
  • 100Day Average: 1012.53
  • 150Day Average: 960.44
  • 200Day Average: 905.92

LLY Indicators & signals

Indicator MACD (12,26,9)

921.21, 935.46, -15.62
Indicator MACD is in negative zone

Indicator ADX (14)

29.71, 17.52, 32.34
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Tue Apr 2026 903.02 881.11 to 913.05 -1.83% 1.95 times
20 Mon Apr 2026 919.90 912.50 to 929.64 -0.77% 0.92 times
17 Fri Apr 2026 927.03 917.80 to 929.99 2.61% 1.56 times
16 Thu Apr 2026 903.43 898.15 to 920.00 -0.18% 0.64 times
15 Wed Apr 2026 905.03 888.03 to 930.00 -1.94% 2.02 times
14 Tue Apr 2026 922.89 915.04 to 939.93 -0.72% 0.59 times
13 Mon Apr 2026 929.55 927.17 to 945.90 -1.07% 1 times
10 Fri Apr 2026 939.57 935.54 to 963.94 -1.64% 0.42 times
09 Thu Apr 2026 955.19 939.29 to 963.76 0.2% 0.8 times
08 Wed Apr 2026 953.30 933.13 to 961.14 2.41% 1.23 times
07 Tue Apr 2026 930.90 898.45 to 932.66 0.46% 0.8 times
06 Mon Apr 2026 926.66 919.78 to 944.44 -0.95% 0.43 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

 

Back to top